{"nct_id":"NCT01220648","title":"Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)","status":"COMPLETED","status_verified_date":"2015-05","start_date":"2012-04","start_date_type":null,"primary_completion_date":"2014-01","primary_completion_date_type":"ACTUAL","completion_date":"2014-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}